A patient with vCJD who showed “remarkable” improvement after a controversial
drug treatment has died after reportedly suffering liver damage. Rachel Forber
was diagnosed with the human form of mad cow disease in June. Two months later
she began a course of chlorpromazine, an antipsychotic, and quinacrine, which is
normally used against malaria. Laboratory tests suggested that both drugs can
block the formation of prions, which cause vCJD. “It’s terrible for hope to be
given and then snatched away like that. We’re right back where we started with
no cure,” says Francis Hall of Britain’s Human BSE Foundation. But authorities
including Britain’s Medical Research Council say her death will not slow
preparations for full-scale trials of the drugs on patients in the US and
Britain.
More from New Scientist
Explore the latest news, articles and features
Space
Hubble Space Telescope is falling to Earth – should NASA save it?
News
Space
A robot called GIMLI will explore a lunar cave for a future moon base
91ɫÇéƬ
91ɫÇéƬ
The economic benefits of the covid vaccines may be double what we thought
News
Humans
Tomb in Siberia reveals humans were using cannabis 2800 years ago
News
Popular articles
Trending New Scientist articles